On Dec. 1, 2022, a panel consisting of chief financial officers (CFOs) and other financial experts convened for a virtual roundtable to discuss the recent economic developments in the life sciences industry and how companies are adapting. The biopharmaceutical sector has not been immune to global economic challenges. After the COVID-19 pandemic generated a wave […]

Finding long-term, non-addictive solutions to manage chronic pain in the U.S. has long been a challenge for biopharma. In the fallout from the opioid pandemic, physicians and researchers are scrambling for options. Tuesday, a panel of experts took on stiff questions about pain/addiction therapeutics during a panel hosted by the Biotechnology Innovation Organizaion (BIO) in […]

Salt Lake City-based Clene, Inc. posted new data Monday from a Phase II trial of CNM-AU8 in multiple sclerosis featuring MRI results it claims reinforce neurological improvements originally reported in August 2022. CNM-AU8, a gold nanocrystal oral therapy, is in development to restore brain health and function by increasing production of ATP, the body’s energy currency. CNM-AU8 is […]